Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure
- 1 January 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 36 (Suppl) , S17-S27
Abstract
Circulating concentrations of B-type natriuretic peptide (BNP) and the aminoterminal fragment (NT-proBNP) of its prohormone (proBNP) are increased in congestive heart failure in proportion to the severity of symptoms, the degree of left ventricular dysfunction, and cardiac filling pressures. Following the introduction of rapid, automated assays for determination of BNP and NT-proBNP, these peptides are increasingly used for diagnostic and prognostic purposes. To review studies evaluating the diagnostic and prognostic value of BNP and NT-proBNP, with special emphasis on their performance as indicators of acute heart failure in the intensive care unit. In patients presenting with acute dyspnea, both BNP and NT-proBNP are accurate indicators of acute heart failure and provide prognostic information above and beyond conventional risk markers. Increased plasma levels of BNP and NT-proBNP are not specific for heart failure and may be influenced by a variety of cardiac and noncardiac conditions commonly seen in the intensive care unit, including myocardial ischemia, cardiac arrhythmias, sepsis, shock, anemia, renal failure, hypoxia, acute pulmonary embolism, pulmonary hypertension, and acute respiratory distress syndrome. The diagnostic performance of BNP and NT-proBNP as indicators of acute heart failure depends on the clinical setting. In the intensive care unit, particular caution should be used in the interpretation of elevated BNP and NT-proBNP levels.Keywords
This publication has 83 references indexed in Scilit:
- Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failureProceedings of the National Academy of Sciences, 2005
- Evaluation and Monitoring of Patients with Acute Heart Failure SyndromesThe American Journal of Cardiology, 2005
- Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of CardiologyEuropean Heart Journal, 2005
- B-type natriuretic peptide in cardiovascular diseaseThe Lancet, 2003
- Cardiac Hormones as Diagnostic Tools in Heart FailureEndocrine Reviews, 2003
- Deconvolution Analysis of Cardiac Natriuretic Peptides During Acute Volume OverloadHypertension, 2000
- Natriuretic HormonesEndocrinology and Metabolism Clinics of North America, 1995
- Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching.Endocrinology, 1993
- Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.Journal of Clinical Investigation, 1991
- A new natriuretic peptide in porcine brainNature, 1988